B
Catalyst Pharmaceuticals, Inc. CPRX
$20.21 -$0.41-1.99% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue 19.44% 43.56% 28.26% 25.33% 23.23%
Total Other Revenue -- -- -- -- --
Total Revenue 19.44% 43.56% 28.26% 25.33% 23.23%
Cost of Revenue 35.79% 44.35% 43.08% -76.94% 14.94%
Gross Profit 16.56% 43.42% 25.43% 2,084.28% 24.81%
SG&A Expenses 12.81% -0.06% 5.13% 36.71% 43.44%
Depreciation & Amortization 0.00% 0.01% 3.15% 10.11% 10.08%
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 17.24% 9.35% 14.67% -44.39% 29.46%
Operating Income 22.22% 133.60% 50.73% 236.90% 16.16%
Income Before Tax 24.21% 145.06% 58.82% 250.46% 15.00%
Income Tax Expenses 14.61% 150.24% 53.80% 283.56% 39.48%
Earnings from Continuing Operations 27.73% 143.77% 60.53% 242.65% 8.03%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 27.73% 143.77% 60.53% 242.65% 8.03%
EBIT 22.22% 133.60% 50.73% 236.90% 16.16%
EBITDA 18.96% 99.22% 42.23% 310.90% 15.22%
EPS Basic 23.55% 134.37% 42.91% 227.81% -2.87%
Normalized Basic EPS 20.39% 118.29% 39.29% 232.64% 7.61%
EPS Diluted 24.24% 136.84% 41.39% 220.69% 0.00%
Normalized Diluted EPS 21.61% 120.71% 40.95% 225.76% 9.15%
Average Basic Shares Outstanding 3.37% 3.99% 12.35% 11.60% 11.22%
Average Diluted Shares Outstanding 2.32% 2.88% 11.01% 17.68% 9.66%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --